There are errors in Table 1. There are multiple incorrect abbreviations in the first column. Please see the corrected Table 1 here.
Table 1. Baseline characteristics of CKD stage 3–4, CKD stage 5-ESRD, and non-CKD groups.
| Characteristics | Non-CKD group (A) | CKD stage 3–4 group (B) |
CKD stage 5-ESRD (C) |
P value | Post-hoc† |
|---|---|---|---|---|---|
| Total | 8213 (90.2%) | 730 (8.0%) | 166 (1.8%) | ||
| Mean age (years) | 58.08±14.15 | 72.30±12.10 | 62.45±13.20 | 0.0001 | A<C<B |
| Gender (Male %) | 4115 (50.1%) | 331 (45.3%) | 80 (48.1%) | 0.044 | A>B>C |
| Presence of chronic illness (% by groups) | |||||
| HTN | 1864 (22.7%) | 413 (56.6%) | 95 (57.2%) | <0.0001 | A<B<C |
| DM | 1462 (17.8%) | 300 (41.1%) | 83 (50.0%) | <0.0001 | A<B<C |
| CVD | 987 (12.0%) | 216 (29.6%) | 51 (30.7%) | <0.0001 | A<B<C |
| LC | 179 (2.2%) | 28 (3.8%) | 9 (5.4%) | 0.001 | A<B<C |
| CHF | 109 (1.3%) | 70 (9.6%) | 17(10.2%) | 0.0001 | A<B<C |
| COPD | 78 (0.9%) | 17 (2.3%) | 2 (1.2%) | 0.002 | A<C<B |
| eGFR (ml/min/1.73 m2) | 92.78±14.86 | 44.49±12.06 | 7.33±3.19 | <0.0001 | C<B<A |
CKD, chronic kidney disease; ESRD, end-stage renal disease; eGFR, estimated glomerular filtration rate; HTN, hypertension; DM, diabetes mellitus; CVD, cardiovascular disease; LC, liver cirrhosis; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease. eGFR was calculated using CKD-EPI formula. Age and eGFR are presented as mean ± standard deviation (SD). Nominal data are presented as percentages
†p-value by student t-test or chi-squared/fisher exact test and adjusted by bonferroni correction
Reference
- 1.Lee HJ, Lee H, Oh SH, Park J, Park S, Jeon JS, et al. (2018) Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. PLoS ONE 13(9): e0203878 10.1371/journal.pone.0203878 [DOI] [PMC free article] [PubMed] [Google Scholar]